BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37748629)

  • 21. Cutaneous T-cell lymphomas with pathogenic somatic mutations and absence of detectable clonal T-cell receptor gene rearrangement: two case reports.
    Rojansky R; Fernandez-Pol S; Wang E; Rieger KE; Novoa RA; Zehnder JL; Kunder CA; Kim YH; Khodadoust MS; Brown RA
    Diagn Pathol; 2020 Sep; 15(1):122. PubMed ID: 32988392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered microRNA expression in folliculotropic and transformed mycosis fungoides.
    Marosvári D; Téglási V; Csala I; Marschalkó M; Bödör C; Timár B; Csomor J; Hársing J; Reiniger L
    Pathol Oncol Res; 2015 Jul; 21(3):821-5. PubMed ID: 25698383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of clonality of cutaneous T-cell lymphomas using polymerase chain reaction].
    Graf A; Kaudewitz P; Simon M; Kind P; Sander CA
    Pathologe; 1996 Nov; 17(6):446-50. PubMed ID: 9082366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonotypic heterogeneity in cutaneous T-cell lymphoma (mycosis fungoides) revealed by comprehensive whole-exome sequencing.
    Iyer A; Hennessey D; O'Keefe S; Patterson J; Wang W; Salopek T; Wong GK; Gniadecki R
    Blood Adv; 2019 Apr; 3(7):1175-1184. PubMed ID: 30967393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
    Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
    J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Notch1 Pathway Activation Results from the Epigenetic Abrogation of Notch-Related MicroRNAs in Mycosis Fungoides.
    Gallardo F; Sandoval J; Díaz-Lagares A; Garcia R; D'Altri T; González J; Alegre V; Servitje O; Crujeiras AB; Stefánsson ÓA; Espinet B; Hernández MI; Bellosillo B; Esteller M; Pujol RM; Bigas A; Espinosa L
    J Invest Dermatol; 2015 Dec; 135(12):3144-3152. PubMed ID: 26302069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adnexotropic and granulomatous mycosis fungoides following TNF-α inhibitor treatment.
    Doughty H; Scripture A; Carter JB; Sriharan A; Yan S; Lansigan F; Momtahen S
    J Cutan Pathol; 2023 Jul; 50(7):611-616. PubMed ID: 37127841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the polymerase chain reaction-based T-cell receptor β clonality test in the diagnosis of early mycosis fungoides.
    Schachter O; Tabibian-Keissar H; Debby A; Segal O; Baum S; Barzilai A
    J Am Acad Dermatol; 2020 Nov; 83(5):1400-1405. PubMed ID: 32526320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma.
    Clark RA; Shackelton JB; Watanabe R; Calarese A; Yamanaka K; Campbell JJ; Teague JE; Kuo HP; Hijnen D; Kupper TS
    Blood; 2011 Feb; 117(6):1966-76. PubMed ID: 21148332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphomas.
    Vandergriff T; Nezafati KA; Susa J; Karai L; Sanguinetti A; Hynan LS; Ambruzs JM; Oliver DH; Pandya AG
    J Cutan Pathol; 2015 May; 42(5):318-28. PubMed ID: 25721994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
    Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
    Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraepidermal localization of the clone in cutaneous T-cell lymphoma.
    Bagot M; Wechsler J; Lescs MC; Revuz J; Farcet JP; Gaulard P
    J Am Acad Dermatol; 1992 Oct; 27(4):589-93. PubMed ID: 1357011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of T-cell receptor gene rearrangements in patients with recurrent patch/plaque (T2) CTCL (mycosis fungoides).
    Thayu M; Tallini G; Glusac EJ; Kacinski BM; Wilson LD
    Yale J Biol Med; 1999; 72(6):365-75. PubMed ID: 11138932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of T-cell antigen losses in mycosis fungoides and CD30-positive cutaneous T-cell lymphoproliferations in a series of 153 patients.
    Wechsler J; Ingen-Housz-Oro S; Deschamps L; Brunet-Possenti F; Deschamps J; Delfau MH; Calderaro J; Ortonne N
    Pathology; 2022 Oct; 54(6):729-737. PubMed ID: 35577607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant microRNA expression in tumor mycosis fungoides.
    Papadavid E; Braoudaki M; Bourdakou M; Lykoudi A; Nikolaou V; Tounta G; Ekonomidi A; Athanasiadis E; Spyrou G; Antoniou C; Kitsiou-Tzeli S; Rigopoulos D; Kolialexi A
    Tumour Biol; 2016 Nov; 37(11):14667-14675. PubMed ID: 27623940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal T cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in the skin and blood of patients with parapsoriasis and early-stage mycosis fungoides.
    Klemke CD; Dippel E; Dembinski A; Pönitz N; Assaf C; Hummel M; Stein H; Goerdt S
    J Pathol; 2002 Jul; 197(3):348-54. PubMed ID: 12115881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miRNA in mycosis fungoides and skin inflammation.
    Persson JL
    APMIS; 2013 Nov; 121(11):1017-9. PubMed ID: 24106870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
    Sibbesen NA; Kopp KL; Litvinov IV; Jønson L; Willerslev-Olsen A; Fredholm S; Petersen DL; Nastasi C; Krejsgaard T; Lindahl LM; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Iversen L; Bonefeld CM; Geisler C; Woetmann A; Odum N
    Oncotarget; 2015 Aug; 6(24):20555-69. PubMed ID: 26244872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sézary syndrome originates from heavily mutated hematopoietic progenitors.
    Harro CM; Sprenger KB; Chaurio RA; Powers JJ; Innamarato P; Anadon CM; Zhang Y; Biswas S; Mandal G; Mine JA; Cortina C; Nagy MZ; Martin AL; Handley KF; Borjas GJ; Chen PL; Pinilla-Ibarz J; Sokol L; Yu X; Conejo-Garcia JR
    Blood Adv; 2023 Sep; 7(18):5586-5602. PubMed ID: 37531660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.